Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-27

Vaccination against prion disease (PRIOVAX)

Objective

Based on prevention of prison disease by transgenic anti-prison protein (Prep) antibody expression in mice, we propose to develop a vaccine to actively induceati-prion immunity in mice. For this purpose, immunological self-tolerance against Prep will be analysed. On that basis recombinant virus vaccines will be developed to explore immunological intervention strategies. The consortium consists of 4 research groups conversing different fields of expertise, i.e. immunology, prison biology, antibody engineering, and recombinant virus technology. The studies will involve advanced technologies to develop new gene targeted mouse models, to establish recombinant Rhabdovirus vaccines, and to optimise anti-PrPantibodies. The results of these studies will explore the feasibility of prionvaccination in mice and will open future perspectives for developing scrapievaccines for animals and humans.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

PAUL-EHRLICH-INSTITUT, FEDERAL AGENCY FOR SERA AND VACCINES
EU contribution
No data
Address
Paul-Ehrlich-Strasse 51-59
63225 LANGEN
Germany

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (2)

My booklet 0 0